BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15751044)

  • 1. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
    McNeil N; Kim JS; Ried T; Janz S
    Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 transgenic mouse model for extraosseous plasmacytoma.
    Kovalchuk AL; Kim JS; Park SS; Coleman AE; Ward JM; Morse HC; Kishimoto T; Potter M; Janz S
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1509-14. PubMed ID: 11805288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell tumour progression in iMycEmu gene-insertion mice.
    Kim JS; Han SS; Park SS; McNeil N; Janz S
    J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
    Silva S; Wiener F; Klein G; Janz S
    Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
    Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells.
    Kovalchuk AL; Kim JS; Janz S
    Oncogene; 2003 May; 22(18):2842-50. PubMed ID: 12743607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
    Park SS; Shaffer AL; Kim JS; duBois W; Potter M; Staudt LM; Janz S
    Cancer Res; 2005 Sep; 65(17):7644-52. PubMed ID: 16140930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
    Wang Y; Sugiyama H; Axelson H; Panda CK; Babonits M; Ma A; Steinberg JM; Alt FW; Klein G; Wiener F
    Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletional remodeling of c-myc-deregulating chromosomal translocations.
    Kovalchuk AL; Müller JR; Janz S
    Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myc translocations in B cell and plasma cell neoplasms.
    Janz S
    DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal translocations deregulating c-myc are associated with normal immune responses.
    Roschke V; Kopantzev E; Dertzbaugh M; Rudikoff S
    Oncogene; 1997 Jun; 14(25):3011-6. PubMed ID: 9223664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
    Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
    Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma.
    Shaughnessy J; Wiener F; Huppi K; Mushinski JF; Potter M
    Oncogene; 1994 Jan; 9(1):247-53. PubMed ID: 8302586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
    Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S
    Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S; Babonits M; Klein G
    Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas].
    Ohno S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents.
    Shaughnessy JD; Owens JD; Wiener F; Hilbert DM; Huppi K; Potter M; Mushinski JF
    Oncogene; 1993 Nov; 8(11):3111-21. PubMed ID: 8414513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
    Wiener F; Coleman A; Mock BA; Potter M
    Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.